SOAT1 and chronic myelogenous leukemia, BCR-ABL1 positive: As reported, CML progression can be promoted by multiple pathways including RAS, PI3K/AKT, ERK, MYC, JAK/STAT, myeloid differentiation, apoptosis, cell cycle, and genomic instability (39).